Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -13.47% is 67% above its 5-year average of -40.82%, near the high end of its 5-year range (-74.46%–-13.47%).
39.38% above its 12-month average of -22.22%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.21%.
RETURN ON ASSETS (ROA)
-13.47%
RETURN ON ASSETS (ROA) AVG TTM
-22.22%
RETURN ON ASSETS (ROA) AVG 3Y
-41.40%
RETURN ON ASSETS (ROA) AVG 5Y
-40.82%
RETURN ON ASSETS (ROA) AVG 10Y
-31.72%
RETURN ON ASSETS (ROA) AVG 15Y
-37.73%
RETURN ON ASSETS (ROA) AVG 20Y
-34.55%
CURRENT VS TTM AVG
+39.38%
CURRENT VS 3Y AVG
+67.47%
CURRENT VS 5Y AVG
+67.00%
CURRENT VS 10Y AVG
+57.53%
CURRENT VS 15Y AVG
+64.30%
CURRENT VS 20Y AVG
+61.01%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+58.22%
vs the sector median at left
Geron Corporation
Market Cap
$789.07M
Return on Assets (ROA)
-13.47%
TTM Avg
-22.22%
3Y Avg
-41.40%
5Y Avg
-40.82%
Market Cap
$786.84M
Return on Assets (ROA)
-5.26%
TTM Avg
0.19%
3Y Avg
-3.34%
5Y Avg
-3.22%
Market Cap
$781.97M
Return on Assets (ROA)
-49.09%
TTM Avg
-55.91%
3Y Avg
-48.67%
5Y Avg
-44.21%
Market Cap
$778.24M
Return on Assets (ROA)
2.01%
TTM Avg
-6.35%
3Y Avg
-2.16%
5Y Avg
-0.48%
Market Cap
$800.49M
Return on Assets (ROA)
-8.70%
TTM Avg
6.33%
3Y Avg
-16.09%
5Y Avg
-46.82%
Market Cap
$803.29M
Return on Assets (ROA)
10.76%
TTM Avg
17.66%
3Y Avg
20.82%
5Y Avg
23.86%
Market Cap
$774.41M
Return on Assets (ROA)
-24.44%
TTM Avg
-47.18%
3Y Avg
-56.01%
5Y Avg
-52.81%
Market Cap
$810.12M
Return on Assets (ROA)
-32.46%
TTM Avg
-61.56%
3Y Avg
-55.11%
5Y Avg
-72.90%
Market Cap
$813.96M
Return on Assets (ROA)
-9.67%
TTM Avg
-10.63%
3Y Avg
-19.71%
5Y Avg
-38.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $789.07M | -13.47% | -22.22% | -41.40% | -40.82% |
| AdaptHealth Corp. (AHCO)vs › | $786.84M | -5.26% | 0.19% | -3.34% | -3.22% |
| Sana Biotechnology, Inc. (SANA)vs › | $781.97M | -49.09% | -55.91% | -48.67% | -44.21% |
| Varex Imaging Corporation (VREX)vs › | $778.24M | 2.01% | -6.35% | -2.16% | -0.48% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $800.49M | -8.70% | 6.33% | -16.09% | -46.82% |
| InMode Ltd. (INMD)vs › | $803.29M | 10.76% | 17.66% | 20.82% | 23.86% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $774.41M | -24.44% | -47.18% | -56.01% | -52.81% |
| Jade Biosciences, Inc. (JBIO)vs › | $810.12M | -32.46% | -61.56% | -55.11% | -72.90% |
| Ardelyx, Inc. (ARDX)vs › | $813.96M | -9.67% | -10.63% | -19.71% | -38.52% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $763.35M | -36.55% | -44.22% | -44.22% | -44.22% |
ROA
-13.5%
ROE
-32.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -15.04% |
| 2024-12-31 | -29.40% |
| 2023-12-31 | -46.72% |
| 2022-12-31 | -74.46% |
| 2021-12-31 | -51.37% |
| 2020-12-31 | -27.93% |
| 2019-12-31 | -41.41% |
| 2018-12-31 | -14.58% |
| 2017-12-31 | -25.31% |
| 2016-12-31 | -22.68% |
| 2015-12-31 | 0.03% |
| 2014-12-31 | -20.68% |
| 2013-12-31 | -56.99% |
| 2012-12-31 | -69.02% |
| 2011-12-31 | -60.52% |
| 2010-12-31 | -47.68% |
| 2009-12-31 | -38.91% |
| 2008-12-31 | -35.20% |
| 2007-12-31 | -16.76% |
| 2006-12-31 | -14.21% |
| 2005-12-31 | -16.66% |
| 2004-12-31 | -60.97% |
| 2003-12-31 | -25.30% |
| 2002-12-31 | -55.89% |
| 2001-12-31 | -43.72% |
| 2000-12-31 | -40.19% |
| 1999-12-31 | -72.84% |
| 1998-12-31 | -24.27% |
| 1997-12-31 | -36.78% |
| 1996-12-31 | -37.15% |
